Literature DB >> 17457661

Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.

J Cázares-Delgadillo1, A Naik, A Ganem-Rondero, D Quintanar-Guerrero, Y N Kalia.   

Abstract

PURPOSE: To demonstrate the transdermal iontophoretic delivery of a small (12.4 kDa) protein across intact skin.
MATERIALS AND METHODS: The iontophoretic transport of Cytochrome c (Cyt c) across porcine ear skin in vitro was investigated and quantified by HPLC. The effect of protein concentration (0.35 and 0.7 mM), current density (0.15, 0.3 or 0.5 mA.cm(-2) applied for 8 h) and competing ions was evaluated. Co-iontophoresis of acetaminophen was employed to quantify the respective contributions of electromigration (EM) and electroosmosis (EO).
RESULTS: The data confirmed the transdermal iontophoretic delivery of intact Cyt c. Electromigration was the principal transport mechanism, accounting for approximately 90% of delivery; correlation between EM flux and electrophoretic mobility was consistent with earlier results using small molecules. Modest EO inhibition was observed at 0.5 mA.cm(-2). Cumulative permeation at 0.3 and 0.5 mA.cm(-2) was significantly greater than that at 0.15 mA.cm(-2); fluxes using 0.35 and 0.7 mM Cyt c in the absence of competing ions (J ( tot ) = 182.8 +/- 56.8 and 265.2 +/- 149.1 microg.cm(-2).h(-1), respectively) were statistically equivalent. Formulation in PBS (pH 8.2) confirmed the impact of competing charge carriers; inclusion of approximately 170 mM Na(+) resulted in a 3.9-fold decrease in total flux.
CONCLUSIONS: Significant amounts ( approximately 0.9 mg.cm(-2) over 8 h) of Cyt c were delivered non-invasively across intact skin by transdermal electrotransport.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457661     DOI: 10.1007/s11095-007-9294-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

1.  High-pressure liquid chromatography quantitation of cytochrome c using 393 nm detection.

Authors:  M J Picklo; J Zhang; V Q Nguyen; D G Graham; T J Montine
Journal:  Anal Biochem       Date:  1999-12-15       Impact factor: 3.365

Review 2.  Iontophoretic drug delivery.

Authors:  Yogeshvar N Kalia; Aarti Naik; James Garrison; Richard H Guy
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

3.  In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin.

Authors:  Ayyappa Chaturvedula; Dipty P Joshi; Carter Anderson; Russell L Morris; Walter L Sembrowich; Ajay K Banga
Journal:  Int J Pharm       Date:  2005-06-13       Impact factor: 5.875

4.  Structure-permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis.

Authors:  Yannic B Schuetz; Pierre-Alain Carrupt; Aarti Naik; Richard H Guy; Yogeshvar N Kalia
Journal:  Eur J Pharm Sci       Date:  2006-06-03       Impact factor: 4.384

5.  Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances.

Authors:  J Hirvonen; R H Guy
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

6.  Effect of amino acid sequence on transdermal iontophoretic peptide delivery.

Authors:  Yannic B Schuetz; Aarti Naik; Richard H Guy; Yogeshvar N Kalia
Journal:  Eur J Pharm Sci       Date:  2005-09-06       Impact factor: 4.384

7.  Transdermal iontophoretic peptide delivery: in vitro and in vivo studies with luteinizing hormone releasing hormone.

Authors:  M C Heit; P L Williams; F L Jayes; S K Chang; J E Riviere
Journal:  J Pharm Sci       Date:  1993-05       Impact factor: 3.534

8.  Contributions of electromigration and electroosmosis to iontophoretic drug delivery.

Authors:  D Marro; Y N Kalia; M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

9.  Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1-34).

Authors:  Y Suzuki; K Iga; S Yanai; Y Matsumoto; M Kawase; T Fukuda; H Adachi; N Higo; Y Ogawa
Journal:  J Pharm Pharmacol       Date:  2001-09       Impact factor: 3.765

10.  Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin) in the rabbit.

Authors:  D T Lau; J W Sharkey; L Petryk; F A Mancuso; Z Yu; F L Tse
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

View more
  7 in total

1.  Structure-skin permeability relationship of dendrimers.

Authors:  Venkata Vamsi Venuganti; Preety Sahdev; Michael Hildreth; Xiangming Guan; Omathanu Perumal
Journal:  Pharm Res       Date:  2011-06-02       Impact factor: 4.200

2.  Iontophoretic skin permeation of peptides: an investigation into the influence of molecular properties, iontophoretic conditions and formulation parameters.

Authors:  Gayathri Krishnan; Michael S Roberts; Jeffrey Grice; Yuri G Anissimov; Hamid R Moghimi; Heather A E Benson
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

3.  Iontophoresis application for drug delivery in high resistivity membranes: nails and teeth.

Authors:  Jayanaraian F Martins Andrade; Thamires da Cunha Miranda; Marcílio Cunha-Filho; Stephânia Fleury Taveira; Guilherme M Gelfuso; Taís Gratieri
Journal:  Drug Deliv Transl Res       Date:  2022-10-08       Impact factor: 5.671

4.  Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue.

Authors:  S Dubey; R Perozzo; L Scapozza; Y N Kalia
Journal:  Int J Pharm X       Date:  2020-07-08

5.  Ultrasonically and Iontophoretically Enhanced Drug-Delivery System Based on Dissolving Microneedle Patches.

Authors:  Moonjeong Bok; Zhi-Jun Zhao; Sohee Jeon; Jun-Ho Jeong; Eunju Lim
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

Review 6.  Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.

Authors:  Ahlam Zaid Alkilani; Maelíosa T C McCrudden; Ryan F Donnelly
Journal:  Pharmaceutics       Date:  2015-10-22       Impact factor: 6.321

7.  Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression.

Authors:  Aditya R Darade; Maria Lapteva; Thomas Hoffmann; Markus Mandler; Achim Schneeberger; Yogeshvar N Kalia
Journal:  Pharmaceutics       Date:  2022-01-08       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.